Clinical Trials Logo

Juvenile Myopia clinical trials

View clinical trials related to Juvenile Myopia.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT05893979 Active, not recruiting - Myopia Clinical Trials

Myopia Control Spectacle Lens Cessation Study

BIRCH
Start date: June 23, 2023
Phase: N/A
Study type: Interventional

To quantify myopic progression (cycloplegic spherical equivalent refraction - cSER) following the cessation of use of specific spectacle lenses. To quantify axial length progression following cessation of use of specific spectacle lenses.

NCT ID: NCT05617794 Active, not recruiting - Myopia Clinical Trials

Effect of Diffusion Optics Technology (DOT) Spectacle Lenses on Choroidal Thickness

ASH-2
Start date: January 18, 2023
Phase: N/A
Study type: Interventional

The objective of the study is to measure the effect of Diffusion Optics Technology (DOT) spectacle lenses on the choroidal thickness and choroidal vascularity index compared to control lenses.

NCT ID: NCT05562622 Active, not recruiting - Myopia Clinical Trials

Assessment of DOT Spectacles in Chinese Children

CATHAY
Start date: February 5, 2023
Phase: N/A
Study type: Interventional

This is a randomized, controlled, evaluator-blinded, multicenter, two-arm parallel group clinical trial of 12-months duration to evaluate the continued safety and efficacy of Diffusion Optics Technology (DOT) spectacle lenses by comparing to single vision, impact-resistant spectacle lenses in reducing the progression of juvenile myopia in children of Chinese origin.

NCT ID: NCT04947735 Active, not recruiting - Myopia Clinical Trials

CYPRESS Efficacy and Safety Study Extension

CYPRESS
Start date: July 19, 2021
Phase: N/A
Study type: Interventional

This is an open-label, controlled, multisite, two-arm parallel group clinical trial of 36-month duration to evaluate the continued safety and efficacy of SightGlass Vision Diffusion Optics Technology (DOT) Spectacles in reducing the progression of juvenile myopia.

NCT ID: NCT03623074 Active, not recruiting - Juvenile Myopia Clinical Trials

Control of Myopia Using Novel Spectacle Lens Designs

CYPRESS
Start date: July 16, 2018
Phase: N/A
Study type: Interventional

Randomized, controlled, multisite, subject-and observer-masked, 3-arm parallel group clinical trial of 36-month duration to evaluate the safety and efficacy of a novel spectacle lens design in reducing the progression of juvenile myopia.